Dr. Silvia D. Orengo-Nania, MD

Dr. Orengo-Nania practices at M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview.

Dr. Orengo-Nania's NPI, 1861481228, was assigned on October 18, 2005. Dr. Orengo-Nania graduated from Baylor College Of Medicine in 1987. Dr. Orengo-Nania holds Minnesota license 76415.

Dr. Orengo-Nania's primary practice is M Health Fairview University of Minnesota Medical Center, at 2450 Riverside Avenue, Minneapolis, MN 55454 in Hennepin County. The practice phone is (612) 624-1765.

Dr. Orengo-Nania's primary practice is M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Dr. Orengo-Nania to 4 more medical groups, 2 group practices and clinics and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Orengo-Nania practices, 4 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Orengo-Nania's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Orengo-Nania is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Orengo-Nania's licenses on file in 3 states: Minnesota, Texas and Pennsylvania.

Dmand AI lists cataract, cataract surgery with lens implant, dry eye, glaucoma, glaucoma surgery, secondary membranaous cataract surgery, vision problems and vitreous eye degeneration among the conditions Dr. Orengo-Nania treats.

CMS data shows 550 Medicare services from Dr. Orengo-Nania across 5 procedure codes in 2024, for 252 Medicare patients. Medicare paid $28,310 for them. Every service was in an office.

CMS counts 252 Medicare patients who saw Dr. Orengo-Nania in 2024. The largest group is 75 to 84, with 115 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 0.95, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Orengo-Nania's median patient age at 73, with 44% women.

In 2024, Dr. Orengo-Nania wrote 1,462 Medicare Part D claims for 294 patients. 54% of them were for generic drugs. CMS names the drug for 1,400 of them, across 21 drugs with 11 or more claims each, at $227,787 in total drug cost. In 2023, CMS named 1,719 claims across 22 drugs.

Dr. Orengo-Nania accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 30 papers to Dr. Orengo-Nania, published from 2013 to 2022. 2021 was the busiest year, with 2. The most frequent topics are Intraocular Pressure, Glaucoma, Open-Angle and Visual Acuity. Dr. Orengo-Nania has published most often in Am J Ophthalmol. Dr. Orengo-Nania's most frequent co-authors are Robert M. Feldman, MD, Sumitra S. Khandelwal, MD and Todd Dana Severin, MD.

Dmand AI links Dr. Orengo-Nania to 2 clinical trials. Conditions studied include Glaucoma, Patient Compliance and Ocular Hypertension.

CMS Open Payments shows 153 general payments to Dr. Orengo-Nania from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 82% of the total. Alcon Laboratories Inc paid the most, $2,737.

Dmand AI lists 2 awards for Dr. Orengo-Nania.

Dr. Orengo-Nania graduated from Baylor College Of Medicine in 1987. Dr. Orengo-Nania is a member of AAO.

Dr. Orengo-Nania is in network with 20 carriers, including Elevance, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.